The Effect of Lowering the Prostate-Specific Antigen Normal Cutoff on Referral Rates to Urology

References

1. 1.↵
   1. Schröder FH,
   2. Hugosson J,
   3. Roobol MJ,
   4. et al

   . Prostate-cancer mortality at 11 years follow-up. N Engl J Med 2012;366:981–90.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Van Leeuwen PJ,
   2. Connolly D,
   3. Tammela TLJ,
   4. et al

   . Balancing harms and benefits of early detection of prostate cancer. Cancer 2010;116:4857–65.

   OpenUrlPubMed
3. 3.↵
   U.S. Preventative Services Task Force. Recommendation statement. Screening for prostate cancer. May 2012. Available at http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm. Accessed September 15, 2012.
4. 4.↵
   National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Prostate cancer early detection version 2.2012. Available at http://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf. Accessed September 20, 2012.
5. 5.↵
   1. Shao YH,
   2. Albertsen PC,
   3. Roberts CB,
   4. et al

   . Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/mL. Arch Intern Med 2010;170:1256–61.

   OpenUrlCrossRefPubMed